Cartesian Therapeutics In...
(RNAC)
undefined
undefined%
At close: undefined
18.68
0.08%
After-hours Dec 13, 2024, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
Net Income | -219.71M | 35.38M | -25.69M | -68.88M | -55.35M | -65.34M | -65.32M | -36.21M | -25.17M | -12.88M |
Depreciation & Amortization | 1.55M | 1.29M | 1.25M | 734.00K | 2.03M | 975.00K | 750.00K | 802.00K | 1.04M | 864.00K |
Stock-Based Compensation | 22.52M | 11.19M | 7.72M | 5.42M | - | - | - | - | - | 1.22M |
Other Working Capital | 1.23M | -64.71M | -45.50M | 94.46M | 1.12M | -265.00K | 9.30M | 9.91M | -87.00K | -1.48M |
Other Non-Cash Items | 158.50M | 2.29M | 2.13M | 1.75M | 16.02M | 8.45M | 9.09M | 830.00K | 2.81M | 193.00K |
Deferred Income Tax | -19.00M | -21.40M | 2.40M | 10.85M | - | - | - | - | - | - |
Change in Working Capital | 4.97M | -60.38M | -48.19M | 85.00M | -4.48M | -781.00K | 7.12M | 13.20M | 427.00K | -2.09M |
Operating Cash Flow | -51.16M | -31.63M | -60.38M | 34.88M | -51.44M | -59.16M | -52.04M | -19.68M | -22.46M | -12.69M |
Capital Expenditures | -206.00K | -1.20M | -1.08M | -815.00K | -47.00K | -884.00K | -733.00K | -586.00K | -1.16M | -227.00K |
Acquisitions | 6.56M | - | - | 74.00K | 122.00K | 99.00K | 4.00K | 2.00K | - | - |
Purchase of Investments | - | -33.50M | -32.45M | - | -18.19M | -15.60M | -61.53M | -28.42M | - | - |
Sales Maturities Of Investments | 28.25M | 19.70M | 16.40M | - | 18.34M | 41.66M | 60.16M | - | - | - |
Other Investing Acitivies | - | - | - | - | - | - | - | 6.90M | -3.52M | - |
Investing Cash Flow | 34.61M | -15.00M | -17.14M | -741.00K | 229.00K | 25.27M | -2.10M | -22.10M | -4.68M | -227.00K |
Debt Repayment | -27.46M | - | - | 5.42M | -2.80M | - | 8.02M | - | 11.43M | 4.49M |
Common Stock Repurchased | -6.17M | - | - | - | - | - | - | - | - | - |
Dividend Paid | - | - | - | - | - | - | - | - | - | - |
Other Financial Acitivies | 20.48M | 235.00K | 939.00K | -3.37M | 70.18M | 697.00K | 886.00K | -3.95M | 32.37M | 20.28M |
Financial Cash Flow | -13.14M | 39.22M | 52.90M | 14.43M | 105.04M | 697.00K | 66.02M | 67.66M | 43.91M | 24.77M |
Net Cash Flow | -29.75M | -7.40M | -24.63M | 48.51M | 52.77M | -33.30M | 11.96M | 25.88M | 16.76M | 8.54M |
Free Cash Flow | -51.37M | -32.83M | -61.47M | 34.07M | -51.48M | -60.05M | -52.77M | -20.27M | -23.63M | -12.91M |